AnaptysBio, Inc. (ANAB)

AnaptysBio Revenue

In the year 2023, AnaptysBio had annual revenue of $17.16M with 66.78% growth. Revenue in the quarter ending December 31, 2023 was $9.01M with 32.27% year-over-year growth.

• Revenue (ttm): $17.16M
• Revenue Growth: +66.78%
• P/S Ratio: 41.94
• Revenue / Employee: $146,641
• Employees: 117
• Market Cap: 719.57M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	17.16M	6.87M	66.78%
Dec 31, 2022	10.29M	-52.89M	-83.72%
Dec 31, 2021	63.18M	-11.83M	-15.77%
Dec 31, 2020	75.00M	67.00M	837.50%
Dec 31, 2019	8.00M	3.00M	60.00%
Dec 31, 2018	5.00M	-5.00M	-50.00%
Dec 31, 2017	10.00M	-6.68M	-40.06%
Dec 31, 2016	16.68M	-887.00K	-5.05%
Dec 31, 2015	17.57M	1.73M	10.94%
Dec 31, 2014	15.84M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.